# Safety & Efficacy of Qurs e Fishar in Mild to Moderate Hypertensive Patients in Pakistan

Study · id `cardio:ct-nct06852079` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06852079](<https://clinicaltrials.gov/study/NCT06852079>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06852079

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 119 participants.

## Technical summary

Registry record NCT06852079. Allocation not applicable; no masking; primary purpose treatment. Start 2023-12-23 (actual); primary completion 2025-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 119 participants (planned count; ClinicalTrials.gov record NCT06852079, source copy `cardio:ctgov-nct06852079-2025-02-28`, retrieved 2026-10-26)
- Started: 2023-12-23 (actual) (ClinicalTrials.gov record NCT06852079, source copy `cardio:ctgov-nct06852079-2025-02-28`, retrieved 2026-10-26)
- Primary completion: 2025-06-30 (anticipated) (ClinicalTrials.gov record NCT06852079, source copy `cardio:ctgov-nct06852079-2025-02-28`, retrieved 2026-10-26)
- Completion: 2025-12-31 (anticipated) (ClinicalTrials.gov record NCT06852079, source copy `cardio:ctgov-nct06852079-2025-02-28`, retrieved 2026-10-26)
- Countries: Pakistan (ClinicalTrials.gov record NCT06852079, source copy `cardio:ctgov-nct06852079-2025-02-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06852079-2025-02-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety & Efficacy of Qurs e Fishar in Mild to Moderate Hypertensive Patients in Pakistan
- Condition: Hypertension
- Intervention (Other): Qurs e Fishar
- Lead sponsor: Abdul Bari
- Lead sponsor class: OTHER
- Collaborator: Hamdard University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

## Provenance

Content hash: f0adc4efbde7db4583c6a3b8908dbd429bca15a48f868c5c222942bdfb1968bd
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
